Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.
about
Complement disorders and hemolytic uremic syndrome.A complementary component to atypical haemolytic uraemic syndrome.Macrovascular involvement in a child with atypical hemolytic uremic syndrome.Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura.How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndromeComplement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission.Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).Long-term Eculizumab Treatment Contributes to Recovery from End-stage Renal Disease Caused by Atypical Hemolytic Uremic SyndromeEffect of eculizumab and recombinant human soluble thrombomodulin combination therapy in a 7-year-old girl with atypical hemolytic uremic syndrome due to anti-factor H autoantibodiesDefective complement inhibitory function predisposes to renal disease.Complement involvement in kidney diseases: From physiopathology to therapeutical targetingTesting the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis.Overcoming technical challenges when treating atypical hemolytic uremic syndrome with therapeutic plasma exchange.The complement cascade and renal disease.Role of complement in glomerular diseases.The Phenotypic Spectrum of Nephropathies Associated with Mutations in Diacylglycerol Kinase ε.A case of atypical hemolytic uremic syndrome associated with the c.1273C>T mutation in the complement C3 gene.Complement factor H mutation associated with membranoproliferative glomerulonephritis with transformation to atypical haemolytic uraemic syndrome.Kidney Diseases Associated With Alternative Complement Pathway Dysregulation and Potential Treatment Options.Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.
P2860
Q33405802-49CAF661-78EC-4BDB-9870-EFE1C0EE08B0Q33408476-EB19F802-E4A1-48AE-83F6-AA7C0E0E4906Q33412191-69A14F0D-952C-4E7D-8D14-F90BC01F3A87Q33412347-A951B454-8989-42CD-A7C9-36041CCC0388Q33412445-D1B0A762-679F-43C0-A47F-2B606464F901Q33416830-12874617-D716-4A0A-A82F-636CACC61C3CQ33417246-A8716740-E9C3-4B40-8DE0-033861FB6B29Q33441517-092A21DF-819E-493B-8D33-ECB72928B5E8Q33441895-A71BFC10-A4E6-49A6-AA71-7D798CA996C7Q34465747-E893FB1C-A968-488A-8484-CA8C76A3DBE1Q35567841-A291DCB5-536E-4570-99FB-7EB10113FEA6Q36978838-93F662FC-CFEB-466C-B348-346C5333E1AEQ37336644-74A019EC-B796-4407-8DC3-428B1C193801Q37502706-CC96CAC6-4129-4C68-BF24-E907997206ABQ38591917-625226C7-7145-4FCD-BF68-502558BDE69CQ40193437-6B0AC4FA-6830-4FB6-A6BC-01A3856397C5Q41359309-E1A08874-ECFC-460D-BCDB-BD22D3938AC3Q41875130-6937E8DD-1A19-4003-887A-93DC1FEB1496Q47327197-7C92BEA6-DE55-4455-8832-62E18E3D10EBQ54489448-F4615B50-B8E8-4D39-B255-F183D0B33A9D
P2860
Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.
@ast
Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.
@en
type
label
Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.
@ast
Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.
@en
prefLabel
Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.
@ast
Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.
@en
P1476
Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.
@en
P2093
David Kavanagh
Timothy H J Goodship
P356
10.1182/ASHEDUCATION-2011.1.15
P577
2011-01-01T00:00:00Z